---
title: "Chery posts 34.6% profit jump in 2025 on strong sales"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279539631.md"
description: "Chery's net income surged 34.6% year-on-year to 19.02 billion yuan ($2.77 billion) in 2025, driven by a record global delivery of 2,631,381 vehicles. Total revenue increased by 11.3% to 300.29 billion yuan. Despite competition, overall gross margin rose to 13.8%. However, the gross margin for core passenger vehicles fell to 12.8%. Chery increased capital expenditure and R&D costs significantly to support growth. The Luxeed and iCar brands saw substantial sales growth, while the Exeed brand experienced a decline. Chery will also acquire a Nissan plant in South Africa."
datetime: "2026-03-18T05:54:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279539631.md)
  - [en](https://longbridge.com/en/news/279539631.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279539631.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/279539631.md) | [繁體中文](https://longbridge.com/zh-HK/news/279539631.md)


# Chery posts 34.6% profit jump in 2025 on strong sales

> -   Chery's net income grew 34.6% year-on-year to 19.02 billion yuan ($2.77 billion) in 2025.
> -   The automaker's overall gross margin expanded to 13.8% in 2025, edging up from 13.5% in 2024.

(A Chery iCar V23 showcased at the Shanghai Auto Show in April 2025. Image credit: CnEVPost)

Chery Automobile's net income jumped 34.6% year-on-year to 19.02 billion yuan ($2.77 billion) in 2025, according to its financial report released Wednesday.

The robust bottom-line result was primarily driven by a record global delivery of 2,631,381 vehicles, representing an 8% increase from 2024.

The company's total revenue for 2025 grew by 11.3% to 300.29 billion yuan.

Join us on Telegram or Google News

Despite facing fierce domestic market competition in its core passenger vehicle segment, Chery's overall gross margin expanded to 13.8% in 2025, slightly up from 13.5% in 2024.

However, as the revenue contribution from new energy vehicles (NEVs) continued to rise, the gross margin for the core passenger vehicle business contracted to 12.8% in 2025 from 13.2% in 2024.

The profit margins currently generated by these emerging NEV products remain significantly lower than those enjoyed by the company's traditional combustion-engine vehicle business.

To support growing global product demand, Chery substantially increased its annual capital expenditure in 2025 to expand production capacity.

The company's selling and distribution expenses jumped 32.6% during the year, reflecting highly aggressive marketing campaigns undertaken by management.

In addition, annual research and development costs climbed 23.8% as the company ramped up R&D investments for future new models.

In terms of sales performance across sub-brands, the emerging Luxeed and iCar brands recorded the fastest growth rates within the group during the year.

Luxeed sold 90,493 vehicles in 2025, a 56% year-on-year increase, while iCar sold 96,989 vehicles, up 47% year-on-year.

In contrast, the premium Exeed brand experienced a 15% annual sales decline to 120,369 vehicles during the year.

Chery to take over Nissan plant in South Africa

Chery South Africa will acquire the land, buildings, and related assets of the Nissan plant by mid-year.

($1 = 6.8774 yuan)

### Related Stocks

- [CHERY AUTO (09973.HK)](https://longbridge.com/en/quote/09973.HK.md)

## Related News & Research

- [Chery Automobile Co., Ltd.(SEHK:9973) added to S&P Global BMI Index](https://longbridge.com/en/news/280140988.md)
- [JLR and Chery present concept study for first Freelander model](https://longbridge.com/en/news/281332660.md)
- [Chery launches QQ3 EV with strong initial orders](https://longbridge.com/en/news/281104519.md)
- [Tata Motors passenger vehicles JLR Q4 sales bounce back after cyber incident](https://longbridge.com/en/news/281507537.md)
- [Chery Once Tried Canada and Never Got to First Base, Could this Comeback be a…](https://longbridge.com/en/news/279465062.md)